Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


ENDOCARDIAL FIBROSIS side effect

What is ENDOCARDIAL FIBROSIS ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   ENDOCARDIAL FIBROSIS and Recently Reported Side Effects   ENDOCARDIAL FIBROSIS and 15 most Active Side Effect polls   ENDOCARDIAL FIBROSIS and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with ENDOCARDIAL FIBROSIS

MAGNEVIST  MITOXANTRONE  


Mitoxantrone Side Effects Report #5427706-X
Consumer or non-health professional from GERMANY reported MITOXANTRONE problem on Aug 15, 2007. Male patient, 58 years of age, was diagnosed with encephalitis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.

Mitoxantrone Side Effects Report #5382147-9
MITOXANTRONE problem was reported by a Health Professional from GERMANY on June 19, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, IV (NOT OTHERWISE SPECIFIED). Patient recovered.

Mitoxantrone Side Effects Report #5388462-7
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 29, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.

Mitoxantrone Side Effects Report #5382147-9
MITOXANTRONE problem was reported by a Health Professional from GERMANY on June 19, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, IV (NOT OTHERWISE SPECIFIED). Patient recovered.


Mitoxantrone Side Effects Report #5388462-7
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 29, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.

Magnevist Side Effects Report #5779183-7
MAGNEVIST problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2008. Male patient, child 11 years of age, weighting 77.16 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, endocardial fibrosis, joint contracture, metaplasia, mobility decreased, muscle contracture, myocardial fibrosis, nephrogenic systemic fibrosis, . MAGNEVIST dosage: TOTAL DAILY DOSE: 10 ML. During the same period patient was treated with OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.

Magnevist Side Effects Report #5781498-3
Consumer or non-health professional from UNITED STATES reported MAGNEVIST problem on June 06, 2008. Male patient, child 11 years of age, weighting 77.16 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with MAGNEVIST. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, endocardial fibrosis, joint contracture, metaplasia, mobility decreased, muscle contracture, myocardial fibrosis, nephrogenic systemic fibrosis, . MAGNEVIST dosage: TOTAL DAILY DOSE: 10 ML. During the same period patient was treated with OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about ENDOCARDIAL FIBROSIS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about ENDOCARDIAL FIBROSIS